Cargando…
Does Nomegestrol Acetate Plus 17β-Estradiol Oral Contraceptive Improve Endometriosis-Associated Chronic Pelvic Pain in Women?
Background: To evaluate the effects of a 24/4 regimen combined oral contraceptive (COC) containing 1.5 mg 17β-estradiol (E2) and 2.5 mg nomegestrol acetate (NOMAC) compared to on-demand nonsteroidal anti-inflammatory drugs (NSAIDs) on women affected by endometriosis-associated chronic pelvic pain (t...
Autores principales: | Caruso, Salvatore, Cianci, Antonio, Iraci, Marco, Fava, Valentina, Di Pasqua, Salvatore, Cianci, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520912/ https://www.ncbi.nlm.nih.gov/pubmed/32678691 http://dx.doi.org/10.1089/jwh.2020.8291 |
Ejemplares similares
-
Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain
por: Caruso, Salvatore, et al.
Publicado: (2022) -
Nomegestrol acetate-17b-estradiol for oral contraception
por: Burke, Anne
Publicado: (2013) -
Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain
por: Caruso, Salvatore, et al.
Publicado: (2019) -
Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability
por: Akintomide, Hannat, et al.
Publicado: (2015) -
The effectiveness of quick starting oral contraception containing nomegestrol acetate and 17-β estradiol on ovulation inhibition: A randomized controlled trial
por: Jirakittidul, Preeyaporn, et al.
Publicado: (2020)